Mutations in SDHC cause autosomal dominant paraganglioma, type 3
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Nonchromaffin paragangliomas (PGLs) are usually benign, neural-crest-derived, slow-growing tumours of parasympathetic ganglia. Between 10% and 50% of cases are familial and are transmitted as autosomal dominant traits with incomplete and age-dependent penetrance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“germline mutations in the B, C and D subunits of SDH predispose individuals to hereditary paragangliomatosis with phaeochromocytomas (HPGL) (2 -6)”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [4]
In the citing paper
“In 2008, mutation of SDH was discovered in cancers such as paraganglioma and pheochromocytoma cells124. Later, similar observations were made in gastrointestinal tumors, neuroblastomas, renal tumors, thyroid tumors, and testicular tumors125,126.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [126]
Citations
Cites
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
PROSPECTIVE RANDOMISED TRIAL OF EARLY DIETARY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE
Rosman, J., Ter Wee, P., Meijer Truus, S., Piers-Becht, P. M., Sluiter, W., & Donker, A. M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90818-3 · Cited by 555
GENOMIC IMPRINTING IN HEREDITARY GLOMUS TUMOURS: EVIDENCE FOR NEW GENETIC THEORY
Van Der Mey, A. L., Maaswinkel-Mooy, P., Cornelisse, C., Schmidt, P., & Van De Kamp, J. P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91908-9 · Cited by 305
Familial carotid body tumors: Case report and epidemiologic review
Grufferman, S., Gillman, M. W., Pasternak, L. R., Peterson, C. L., & Young, W. G. (1980) · Cancer · doi:10.1002/1097-0142(19801101)46:9<2116::aid-cncr2820460934>3.0.co;2-s · Cited by 240
Heutink, P., Mey, A. G. L. V. D., Sandkuijl, L. A., Gils, A. P. G. V., Bardoel, A., Breedveld, G. J., Vliet, M. V., Ommen, G.-J. B. V., Cornelisse, C. J., Oostra, B. A., et al. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.1.7 · Cited by 214
Mariman, E. C. M., van Beersum, S. E. C., Cremers, C. W. R. J., Struycken, P., & Ropers, H. (1995) · Human Genetics · doi:10.1007/bf00225075 · Cited by 136
Hirawake, H., Taniwaki, M., Tamura, A., Kojima, S., & Kita, K. (1997) · Cytogenetic and Genome Research · doi:10.1159/000134700 · Cited by 62
Repositioning the hereditary paraganglioma critical region on chromosome band 11q23
Baysal, B. E., van Schothorst, E. M., Farr, J. E., Grashoff, P., Myssiorek, D. J., Rubinstein, W. S., Taschner, P. E. M., Cornelisse, C. J., Devlin, B., Devilee, P., et al. (1999) · Human Genetics · doi:10.1007/s004390050939 · Cited by 58
PGL3 , a third, not maternally imprinted locus in autosomal dominant paraganglioma
Niemann, S., Steinberger, D., & Müller, U. (1999) · Neurogenetics · doi:10.1007/s100480050078 · Cited by 54
Self-citation
Cited by
Items 401–500 of 938
Paraganglioma Syndrome: SDHB, SDHC, and SDHD Mutations in Head and Neck Paragangliomas
Schiavi, F., Savvoukidis, T., Trabalzini, F., Grego, F., Piazza, M., Amistà, P., Demattè, S., Piano, A. D., Cecchini, M. E., Erlic, Z., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.020 · Cited by 41
Perry, C. G., Young, W. F., McWhinney, S. R., Bei, T. A., Stergiopoulos, S. G., Knudson, R. A., Ketterling, R. P., Eng, C., Stratakis, C. A., & Carney, J. A. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000178087.69394.9f · Cited by 41
Epigenetics of pheochromocytoma and paraganglioma
Björklund, P., & Backman, S. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.06.016 · Cited by 40
Ricci, L., Stanley, F. U., Eberhart, T., Mainini, F., Sumpton, D. P., & Cardaci, S. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05927-5 · Cited by 40
Pandit, R., Khadilkar, K. S., Sarathi, V., Kasaliwal, R., Goroshi, M., Khare, S., Nair, S. V. G., Raghavan, V., Dalvi, A. N., Hira, P., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0126 · Cited by 40
Livesey, K., Wimhurst, V. L. C., Carter, K., Worwood, M., Cadet, E., Rochette, J., Roberts, A. G., Pointon, J. J., Merryweather-Clarke, A. T., Bassett, M. L., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.008805 · Cited by 40
The first Dutch SDHB founder deletion in paraganglioma – pheochromocytoma patients
Bayley, J., Grimbergen, A., van Bunderen, P. A., van der Wielen, M. J. R., Kunst, H. P. M., Lenders, J. W. M., Jansen, J. C., Dullaart, R. P. F., Devilee, P., Corssmit, E. P. M., et al. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-34 · Cited by 40
“The identification in HN-PGL families of germline mutations of SDHD (succinate dehydrogenase, subunit D) [2] was soon followed by the identification of germline mutations in SDHB [3] and SDHC [4].”
BackgroundBaysal, B. E., Lawrence, E. C., & Ferrell, R. E. (2007) · BMC Biology · doi:10.1186/1741-7007-5-12 · Cited by 39
“Since then, mutations in SDHB, SDHC, and SDHD subunit genes (PGL genes) have been established as an important cause of sporadic and familial paragangliomas [5-10].”
BackgroundPhosphoglycerate Dehydrogenase: Potential Therapeutic Target and Putative Metabolic Oncogene
Zogg, C. K. (2014) · Journal of Oncology · doi:10.1155/2014/524101 · Cited by 39
Tufton, N., Shapiro, L., Srirangalingam, U., Richards, P. S., Sahdev, A., Kumar, A., McAndrew, L., Martin, L., Berney, D. M., Monson, J. P., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.13246 · Cited by 39
Yuan, T., Zhou, T., Qian, M., Du, J., Liu, Y., Wang, J., Li, Y., Fan, G., Yan, F., Dai, X., et al. (2022) · Hepatology · doi:10.1002/hep.32621 · Cited by 39
Mitochondrial superoxide anion (O2·-) inducible "mev-1" animal models for aging research
Ishii, T., Miyazawa, M., Hartman, P. S., & Ishii, N. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.5.298 · Cited by 39
“We be- lieve that the mev-1 like cell lines are suitable models for the tumorigenesis in human such as ‘PGL/PHEO syndrome’.”
BackgroundInfluentialSaito, Y., Ishii, K., Aita, Y., Ikeda, T., Kawakami, Y., Shimano, H., Hara, H., & Takekoshi, K. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1738-3 · Cited by 39
Bourdeau, I., Grunenwald, S., Burnichon, N., Khalifa, E., Dumas, N., Binet, M.-C., Nolet, S., & Gimenez‐Roqueplo, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1665 · Cited by 39
“The SDHC mutation related toPGLs,which is referred toasparaganglioma type 3, was first described in 2000 by Niemann and Muller (8).”
BackgroundParagangliomas of the Carotid Body: Current Management Protocols and Review of Literature
Naik, S. M., Shenoy, A. M., Nanjundappa, Halkud, R., Chavan, P., Sidappa, K., Amirtham, U., & Gupta, S. (2013) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-013-0249-4 · Cited by 40
Sandgren, J., de Ståhl, T. D., Andersson, R., Menzel, U., Piotrowski, A., Nord, H., Bäckdahl, M., Kiss, N. B., Brauckhoff, M., Komorowski, J., et al. (2010) · Endocrine Related Cancer · doi:10.1677/erc-09-0310 · Cited by 38
“…type 1 respectively (Xu et al. 1992, Latif et al. 1993, Mulligan et al. 1993), whereas germline mutations in SDHB, SDHC, SDHD and SDH5 genes have been found in paraganglioma syndromes (Baysal et al. 2000, Niemann & Muller 2000, Astuti et al. 2001a,b, Eng et al. 2003, Hao et al. 2009).”
BackgroundGrowth Rate of Paragangliomas Related to Germline Mutations of the SDHx Genes
Michałowska, I. M., Ćwikła, J. B., Michalski, W., Wyrwicz, L. S., Prejbisz, A., Szperl, M., Nieć, D., Neumann, H. P. H., Januszewicz, A., & Pęczkowska, M. (2016) · Endocrine Practice · doi:10.4158/ep161377.or · Cited by 38
Oudijk, L., Gaal, J., & de Krijger, R. R. (2018) · Endocrine Pathology · doi:10.1007/s12022-018-9555-2 · Cited by 38
Molecular pathogenesis of tumorigenesis caused by succinate dehydrogenase defect
Moosavi, B., Zhu, X., Yang, W., & Yang, G. (2019) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2019.151057 · Cited by 38
Liu, X., Qiao, Y., Ting, X., & Si, W. (2020) · PubMed · Cited by 38
Reduced quality of life in patients with head-and-neck paragangliomas
Havekes, B., van der Klaauw, A. A., Hoftijzer, H. C., Jansen, J. C., van der Mey, A. G. L., Vriends, A. H. J. T., Smit, J. W. A., Romijn, J. A., & Corssmit, E. P. M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0464 · Cited by 38
Aykin‐Burns, N., Slane, B. G., Liu, A. T. Y., Owens, K. M., O'Malley, M. S., Smith, B. J., Domann, F. E., & Spitz, D. R. (2010) · Radiation Research · doi:10.1667/rr2220.1 · Cited by 38
“In addition, mutations in genes coding for SDHB, C and D have been associated with increased susceptibility to induction of paragangliomas and pheochromocytomas in humans (14, 15).”
BackgroundSchaefer, I., Hornick, J. L., & Bovée, J. V. M. G. (2018) · Laboratory Investigation · doi:10.1038/s41374-017-0003-6 · Cited by 38
“SDH-deficient GISTs—including GISTs with SDHx subunit mutations and SDHC promoter methylation— share a common genome-wide hypermethylation phenotype, as the unifying oncogenic mechanism [81].”
InfluentialActive succinate dehydrogenase (SDH) and lack of SDHD mutations in sporadic paragangliomas.
Braun, S., Riemann, K., Kupka, S., Leistenschneider, P., Sotlar, K., Schmid, H., & Blin, N. (2005) · PubMed · Cited by 38
Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma
Vícha, A., Taïeb, D., & Pacák, K. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0398 · Cited by 37
“…(RET; Mulligan et al. 1993), the von Hippel–Lindau (VHL; Latif et al. 1993) tumor suppressor, the SDH subunits (SDHA/B/C/D; Baysal et al. 2000, Niemann & Muller 2000, Astuti et al. 2001, Burnichon et al. 2010), SDH complex assembly factor 2 (SDHAF2; Hao et al. 2009), transmembrane protein…”
Integrative epigenomic and genomic analysis of malignant pheochromocytoma
Sandgren, J., Andersson, R., Rada-Iglesias, Á., Enroth, S., Åkerström, G., Dumanski, J. P., Komorowski, J., Westin, G., & Wadelius, C. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.7.050 · Cited by 37
“Mutations in the proto-oncogene RET or the tumor suppressor genes VHL, NF1, SDHD, SDHC, and SDHB predisposes to tumor development in these disorders (Xu et al., 1992; Latif et al., 1993; Mulligan et al., 1993; Baysal et al., 2000; Niemann and Muller 2000; Astuti et al., 2001a, 2001b).”
BackgroundHigh prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations
Heesterman, B. L., Bayley, J., Tops, C. M. J., Hes, F. J., van Brussel, B. T. J., Corssmit, E. P. M., Hamming, J. F., van der Mey, A. G. L., & Jansen, J. C. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.203 · Cited by 37
Consensus Statement and Guidelines on the Management of Paragangliomas of the Head and Neck
Gjurić, M., & Gleeson, M. J. (2009) · Skull base · doi:10.1055/s-0028-1103131 · Cited by 37
“from research groups around the world have identified a total of 120 variants.(7,8) Approximately 30% of apparently sporadic H&N PGLs are caused by a germline mutation in one of the genes SDHB, SDHC, and SDHD.”
BackgroundRecent Insights into the Molecular Pathogenesis of Pheochromocytoma and Paraganglioma
Nakamura, E., & Kaelin, W. G. (2006) · Endocrine Pathology · doi:10.1385/ep:17:2:97 · Cited by 37
Suarez, C. M., Sevilla, M. A., & Llorente, J. L. (2007) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-007-0267-3 · Cited by 37
How many pathways to pheochromocytoma?
Neumann, H. P. H., Hoegerle, S., Manz, T., BRENNER, K. R., & Iliopoulos, O. (2002) · Seminars in Nephrology · doi:10.1053/snep.2002.30207 · Cited by 37
Malignancy in pheochromocytomas. Review article
Salmenkivi, K., Heikkilä, P., Haglund, C. H., & Arola, J. T. (2004) · Apmis · doi:10.1111/j.1600-0463.2004.apm1120901.x · Cited by 37
Keatley, K., Stromei-Cleroux, S., Wiltshire, T., Rajala, N. K. M., Burton, G., Holt, W. V., Littlewood, D. T. J., Briscoe, A. G., Jung, J., Ashkan, K., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133364 · Cited by 36
Turner, S. T., Fornage, M., Jack, C. R., Mosley, T. H., Knopman, D. S., Kardia, S. L. R., Boerwinkle, E., & de Andrade, M. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.110 · Cited by 36
Fliedner, S. M. J., Kaludercic, N., Jiang, X.-S., Hansíková, H., Hájková, Z., Sládková, J., Limpuangthip, A., Backlund, P. S., WESLEY, R. A., Martiniova, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040949 · Cited by 36
“Mutations of the SDHx genes can cause pheochromocytomas (PHEOs) and paragangliomas (PGLs) [11,12,13,14].”
BackgroundHensen, E. F., Jansen, J. C., Siemers, M., Oosterwijk, J. C., Vriends, A. H. J. T., Corssmit, E. P. M., Bayley, J., van der Meij, A. G. L., Cornelisse, C. J., & Devilee, P. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.112 · Cited by 36
Genetic Testing for Pheochromocytoma-associated Syndromes
Pawlu, C., Bausch, B., Reisch, N., & Neumann, H. P. H. (2005) · Annales d Endocrinologie · doi:10.1016/s0003-4266(05)81749-4 · Cited by 36
Routine genetic screening with a multi-gene panel in patients with pheochromocytomas
Sbardella, E., Cranston, T., Isidori, A. M., Shine, B. S. F., Pal, A., Jafar‐Mohammadi, B., Sadler, G., Mihai, R., & Grossman, A. B. (2017) · Endocrine · doi:10.1007/s12020-017-1310-9 · Cited by 35
Tufton, N., Sahdev, A., Drake, W. M., & Akker, S. A. (2018) · Clinical Endocrinology · doi:10.1111/cen.13877 · Cited by 35
Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration
Cascón, A., Remacha, L., Calsina, B., & Robledo, M. (2019) · Cancers · doi:10.3390/cancers11050683 · Cited by 35
“Though SDHC was the second SDHx gene identified as a cause of hereditary PGL (PGL type 3) [5], the frequency of patients carrying mutations in this gene is much lower than SDHB- and SDHD-related PPGLs, accounting for less than 1% of the patients.”
BackgroundGuha, A., Musil, Z., Vícha, A., Zelinka, T., Pacák, K., Astl, J., & Chovanec, M. (2019) · Neoplasma · doi:10.4149/neo_2018_181208n933 · Cited by 35
Yamazaki, Y., Gao, X., Pecori, A., Nakamura, Y., Tezuka, Y., Omata, K., Ono, Y., Morimoto, R., Satoh, F., & Sasano, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.587769 · Cited by 35
“3 Germline PGL>>PHEO Very low Famlilial PGL type 3 (15)”
BackgroundOxygen Concentration Controls Epigenetic Effects in Models of Familial Paraganglioma
Her, Y. F., Nelson-Holte, M. H., & Maher, L. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127471 · Cited by 35
Flynn, A., Dwight, T., Harris, J., Benn, D. E., Zhou, L., Hogg, A., Catchpoole, D. R., James, P. A., Duncan, E. L., Trainer, A. H., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3889 · Cited by 35
Models of parent-of-origin tumorigenesis in hereditary paraganglioma
Hoekstra, A. S., Devilee, P., & Bayley, J. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.05.011 · Cited by 35
Germline SDHB Mutations are Common in Patients With Apparently Sporadic Sympathetic Paragangliomas
Klein, R. D., Jin, L. G., Rumilla, K. M., Young, W. F., & Lloyd, R. V. (2008) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e318150d67c · Cited by 34
Adrenal Medulla and Paraganglia
McNicol, A. M. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1069-1_12 · Cited by 34
Dannenberg, H., de Krijger, R. R., Zhao, J., Speel, E. M., Saremaslani, P., Dinjens, W. N. M., Mooi, W. J., Roth, J., Heitz, P. U., & Komminoth, P. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64662-7 · Cited by 34
“Recently, a third, not maternally imprinted gene was demonstrated to cause PGL in a German family (PGL3).(21) Although substantial progress has thus been made in the identification of genetic changes involved in the development of hereditary PGL, comparative data on genomic changes in sporadic and familial parasympath…”
Molecular Genetic Alterations in Adrenal and Extra-Adrenal Pheochromocytomas and Paragangliomas
Dannenberg, H., Komminoth, P., Dinjens, W. N. M., Speel, E. M., & de Krijger, R. R. (2003) · Endocrine Pathology · doi:10.1385/ep:14:4:329 · Cited by 34
Endocrine Hypertension: Then and Now
Young, W. F. (2010) · Endocrine Practice · doi:10.4158/ep10205.ra · Cited by 33
“Subsequently, mutations in the other succinate dehydrogenase subunit genes (SDHB, SDHC, SDHA, and SDHAF2), which compose portions of mitochondrial complex II, were identified and associated with familial paraganglioma (72-74).”
BackgroundIsocitrate dehydrogenase 1/2 mutational analyses and 2‐hydroxyglutarate measurements in Wilms tumors
Rakheja, D., Mitui, M., Boriack, R. L., & DeBerardinis, R. J. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22697 · Cited by 33
Kuo, C., Cheng, C.-T., Hou, P., Lin, Y.-P., Ma, H., Chung, Y., Chi, K. K., Chen, Y., Li, W., Kung, H.-J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8570 · Cited by 33
Pandit, R., Khadilkar, K. S., Sarathi, V., Kasaliwal, R., Goroshi, M., Khare, S., Nair, S. V. G., Raghavan, V., Dalvi, A. N., Hira, P., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0126e · Cited by 33
Bayley, J., Bausch, B., Rijken, J. A., van Hulsteijn, L. T., Jansen, J. C., Ascher, D. B., Pires, D. E. V., Hes, F. J., Hensen, E. F., Corssmit, E. P. M., et al. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106214 · Cited by 33
Pathophysiology and Diagnosis of Disorders of the Adrenal Medulla: Focus on Pheochromocytoma
Lenders, J. W. M., & Eisenhofer, G. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130034 · Cited by 32
Differential metabolic consequences of fumarate hydratase and respiratory chain defects
Raimundo, N., Ahtinen, J., Fumić, K., Barić, I., Remes, A. M., Renkonen, R., Lapatto, R., & Suomalainen, A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.008 · Cited by 32
Rapizzi, E., Ercolino, T., Fucci, R., Zampetti, B., Felici, R., Guasti, D., Morandi, A., Giannoni, E., Giaché, V., Bani, D., et al. (2014) · Hormones and Cancer · doi:10.1007/s12672-014-0172-3 · Cited by 32
“These genes include those encoding the four subunits of the succinate dehydrogenase (SDHA, SDHB, SDHC and SDHD) [4–7] and SDHAF2, which is responsible for the flavination of the SDHA subunit [8].”
BackgroundAdrenal disease: a clinical update and overview of imaging. A review
Čtvrtlík, F., Koranda, P., & Tichý, T. (2014) · Biomedical Papers · doi:10.5507/bp.2014.010 · Cited by 32
Pęczkowska, M., Erlic, Z., Hoffmann, M. M., Furmanek, M. I., Ćwikła, J. B., Kubaszek, A., Prejbisz, A., Szutkowski, Z., Kawecki, A., Chojnowski, K., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1290 · Cited by 32
Mitochondrial Diseases ‐ An Expanding Spectrum of Disorders and Affected Genes
von Kleist-Retzow, J., Schauseil-Zipf, U., Michalk, D. V., & Kunz, W. S. (2003) · Experimental Physiology · doi:10.1113/eph8802509 · Cited by 32
“(Niemann & Muller, 2000) SDH-D Anchoring subunit ad PGL1 ?”
Identification of Succinate Dehydrogenase–deficient Bladder Paragangliomas
Mason, E. F., Sadow, P. M., Wagner, A. J., Remillard, S. P., Flood, T. A., Belanger, E. C., Hornick, J. L., & Barletta, J. A. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318293d83c · Cited by 31
Succinate dehydrogenase complex subunit C: Role in cellular physiology and disease
Wang, Q., Li, M., Zeng, N., Zhou, Y., & Yan, J. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702221147567 · Cited by 31
Shen, T., Wang, H., Tang, B., Zhu, G., & Wang, X. (2023) · RNA Biology · doi:10.1080/15476286.2023.2216562 · Cited by 31
Morgan, C. C., Shakya, K., Webb, A. E., Walsh, T., Lynch, M. J., Loscher, C. E., Ruskin, H. J., & O’Connell, M. J. (2012) · BMC Evolutionary Biology · doi:10.1186/1471-2148-12-114 · Cited by 31
“Defects in this protein are reported in paragangliomas and gastric stromal sarcomas [62].”
BackgroundCarney triad, SDH-deficient tumors, and Sdhb+/− mice share abnormal mitochondria
Szarek, E., Ball, E. R., Impériale, A., Tsokos, M., Faucz, F. R., Giubellino, A., Moussallieh, F., Namer, I. J., Abu-Asab, M. S., Pacák, K., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0069 · Cited by 31
“…are encoded by nuclear genes, and SDHx-deficient tumors bear inactivating germline mutations as well as a loss of the corresponding normal allele (Baysal et al. 2000, Niemann & Muller 2000, Astuti et al. 2001, Velasco et al. 2005, Burnichon et al. 2010, Gill et al. 2011, Celestino et al. 2012).”
The embryonic developmental effect of sedaxane on zebrafish (Danio rerio)
Yao, H., Yu, J., Zhou, Y., Xiang, Q., & Xu, C. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.01.046 · Cited by 31
Raygada, M. J., Pasini, B., & Stratakis, C. A. (2011) · Advances in oto-rhino-laryngology · doi:10.1159/000322484 · Cited by 31
Role of ultrasound and color Doppler imaging in the detection of carotid paragangliomas
Demattè, S., Sarra, D. D., Schiavi, F., Casadei, A., & Opocher, G. (2012) · Journal of Ultrasound · doi:10.1016/j.jus.2012.05.001 · Cited by 31
“Type 3 (PGL3): SDHC gene mutation [12]; 4.”
BackgroundSDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas
Mhatre, A., Li, Y., Feng, L., Gasperin, A. C. H., & Lalwani, A. K. (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00328.x · Cited by 31
“No mutations of SDHC have been identified in these mutation screen; to date, only one family with familial PGL has been identified with mutation in SDHC (3).”
BackgroundThe expanding spectrum of nuclear gene mutations in mitochondrial disorders
Zeviani, M. (2001) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2001.0278 · Cited by 31
Maternal Transmission of Symptomatic Disease withSDHDMutation: Fact or Fiction?
Neumann, H. P. H., & Erlic, Z. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0569 · Cited by 31
microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance
Zhang, W. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236094 · Cited by 30
“0 (Broad Institute) [19,20], the succinate dehydrogenase complex [21] inclusive of succinate dehydrogenase A [22], succinate dehydrogenase B [23], succinate dehydrogenase C [24], and succinate dehydrogenase D [25], as well as glycine decarboxylase [26–29] and glutaminase [30], is especially critical for tumorigenesis.”
BackgroundPheochromocytoma: implications in tumorigenesis and the actual management.
Shah, U. A., Giubellino, A., & Pacák, K. (2012) · PubMed · Cited by 30
Lin, A., Anderson, S. L., Minard, K. I., & McAlister-Henn, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.266890 · Cited by 30
Rapizzi, E., Ercolino, T., Canu, L., Giaché, V., Francalanci, M., Pratesi, C., Valeri, A., & Mannelli, M. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0263 · Cited by 30
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: beyond pheochromocytomas and paragangliomas
Mannelli, M., Canu, L., Ercolino, T., Rapizzi, E., Martinelli, S., Parenti, G., Filpo, G. D., & Nesi, G. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0523 · Cited by 30
Pheochromocytoma: Gasping for Air
Jochmanová, I., Zhuang, Z., & Pacák, K. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0231-4 · Cited by 30
Pathophysiology of Hypertension
Yamaguchi, I., & Flynn, J. T. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_61 · Cited by 30
“In addition to the genes mentioned above, mutations of succinate dehydrogenase subunit genes (SDHB, SDHC, SDHD, SDHAF2, SDHA), a part of the mitochondrial complex, have been found [404–409].”
BackgroundHuang, L.-S., Borders, T. M., Shen, J. T., Wang, C.-J., & Berry, E. A. (2005) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905000181 · Cited by 30
“Perhaps related to this, Complex II subunits have been identified as tumor suppressors (Baysal et al. 2000; McDonnell et al. 2004; Niemann and Muller 2000) Complex II is also a target or potential target for agrochemical and clinical drugs, for example the fungicide flutolanil has recently been…”
BackgroundLips, C. J. M., Lentjes, E. G. W. M., Höppener, J. W. M., van der Luijt, R. B., & Moll, F. L. (2006) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-4-4-169 · Cited by 30
“Also mutations in this gene may cause hereditary paragangliomas; however, these mutations occur less frequently than SDHD mutations [8].”
BackgroundLima, J. P., Teixeira-Gomes, J., Soares, P., Máximo, V., Honavar, M., Williams, E. D., & Sobrinho-Simões, M. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030008 · Cited by 30
Wilms Tumor in a Child with L-2-hydroxyglutaric Aciduria
Rogers, R. E., DeBerardinis, R. J., Klesse, L. J., Boriack, R. L., Margraf, L. R., & Rakheja, D. (2010) · Pediatric and Developmental Pathology · doi:10.2350/09-12-0768-cr.1 · Cited by 29
Tumour microenvironment in pheochromocytoma and paraganglioma
Martinelli, S., Amore, F., Canu, L., Maggi, M., & Rapizzi, E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1137456 · Cited by 29
Patócs, A., Karádi, É., Tóth, M., Varga, I., Szücs, N., Balogh, K., Majnik, J., Gláz, E., & Rácz, K. (2004) · European Journal of Cancer Prevention · doi:10.1097/00008469-200410000-00008 · Cited by 29
“Recently, germline mutations of the genes encoding for succinate dehydrogenase (SDH, mitochondrial complex II) subunits (SDHD, SDHB and SDHC) have been identified in patients with familial head and neck paragangliomas (Baysal et al., 2000; Niemann and Muller, 2000; Astuti et al., 2001) and SDHD and SDHB gene mutations…”
BackgroundHolt, D. E., Henthorn, P. S., Howell, V. M., Robinson, B. G., & Benn, D. E. (2014) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2014.03.007 · Cited by 29
Evenepoel, L., van Nederveen, F. H., Oudijk, L., Papathomas, T. G., Restuccia, D. F., Belt, E. J. T., de Herder, W. W., Feelders, R. A., Franssen, G. J. H., Hamoir, M., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01314 · Cited by 29
Functional and in silico assessment of MAX variants of unknown significance
Comino‐Méndez, I., Leandro-Garcia, L. J., Montoya, G., Inglada‐Pérez, L., de Cubas, A. A., Currás-Freixes, M., Tysoe, C. J., Izatt, L., Letón, R., Gómez-Graña, Á., et al. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1306-y · Cited by 29
Paragangliomas of the head and neck
Kupferman, M. E., & Hanna, E. Y. (2008) · Current Oncology Reports · doi:10.1007/s11912-008-0024-9 · Cited by 29
La génétique des paragangliomes et des phéochromocytomes
Favier, J., & Gimenez‐Roqueplo, A. (2012) · médecine/sciences · doi:10.1051/medsci/2012286016 · Cited by 29
“Après l’identification des gènes SDHD (succinate dehydrogenase complex, subunit D) [5], SDHC [6] et SDHB [7] dans les années 2000-2001, il apparut qu’au moins un quart des PGL/PCC étaient en fait héréditaires.”
BackgroundYao, L., Barontini, M., Niederle, B., Jech, M., Pfragner, R., & Dahia, P. L. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2245 · Cited by 27
Adrenal medulla and extra-adrenal paraganglia
Oudijk, L., de Krijger, R. R., Pacák, K., & Tischler, A. S. (2000) · Cited by 29
External-beam radiation therapy for malignant paraganglioma of the head and neck
Gilbo, P., Tariq, A., Morris, C. G., & Mendenhall, W. M. (2015) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2015.06.004 · Cited by 28
“succinate dehydrogenase (SDH) [9–11], VHL, RET, and NF1 [12,13].”
BackgroundUpdate on paragangliomas and pheochromocytomas
Lam, A. K.-Y. (2015) · Turkish Journal of Pathology · doi:10.5146/tjpath.2015.01318 · Cited by 28
Surgery of vagal paragangliomas: Six patients and review of literature
Lozano, F. S., Gómez, J. L., Mondillo, M. C., González‐Porras, J. R., González‐Sarmiento, R., & Muñoz, A. (2008) · Surgical Oncology · doi:10.1016/j.suronc.2008.03.001 · Cited by 28
Markevich, N. I., Galimova, M. H., & Markevich, L. N. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101630 · Cited by 27
Quality of life is decreased in patients with paragangliomas
van Hulsteijn, L. T., Louisse, A., Havekes, B., Kaptein, A. A., Jansen, J. C., Hes, F. J., Smit, J. W. A., & Corssmit, E. P. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0968 · Cited by 27
Targeting succinate:ubiquinone reductase potentiates the efficacy of anticancer therapy
Kruspig, B., Valter, K., Skender, B., Zhivotovsky, B., & Gogvadze, V. G. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.04.026 · Cited by 27
High-Throughput Screening for Growth Inhibitors Using a Yeast Model of Familial Paraganglioma
Bancos, I., Bida, J. P., Tian, D., Bundrick, M., John, K., Holte, M. N., Her, Y. F., Evans, D. L., Saenz, D. T., Poeschla, E. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056827 · Cited by 27
“Our work focuses on PGL models [18] based on disruption of the SDHB gene where mutations commonly cause extra-adrenal metastatic PGL [2,10,19].”
BackgroundHavekes, B., van der Klaauw, A. A., Weiss, M. M., Jansen, J. C., van der Mey, A. G. L., Vriends, A. H. J. T., Bonsing, B. A., Romijn, J. A., & Corssmit, E. P. M. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0024 · Cited by 27
“…in Great syndromes are associated with germ-line mutations in the genes encoding subunits of mitochondrial complex II succinate dehydrogenase (SDH): SDHD, SDHC, and SDHB (van der Mey et al. 1989, Baysal et al. 2000, Niemann & Muller 2000, Astuti et al. 2001, Koch et al. 2002, Benn & Robinson 2006).”
Backgroundde Bresser, C. J. M., & de Krijger, R. R. (2024) · Endocrine Pathology · doi:10.1007/s12022-024-09830-3 · Cited by 27
Metadata
- Authors
- Niemann, S., & Müller, U.
- Affiliations
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- Müller, Ulrich
- ORCID
- Müller, Ulrich
- Venue
- Nature Genetics
- Published
- 2000-11
- Volume
- 26
- Issue
- 3
- Pages
- 268-270
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1528834211
- Cited by
- 875
- References
- 9
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 9 · 2023: 18 · 2022: 14 · 2021: 24 · 2020: 24 · 2019: 35 · 2018: 27 · 2017: 36 · 2016: 36 · 2015: 44 · 2014: 59 · 2013: 49 · 2012: 72
- FWCI
- 32.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- SDHC, nonchromaffin paraganglioma, autosomal dominant inheritance, familial paraganglioma, neural crest tumors, parasympathetic ganglia, penetrance
- MeSH terms
- Chromosomes, Human, Pair 1, DNA Mutational Analysis, Female, Genes, Dominant, Humans, Male, Membrane Proteins, Mitochondria, Molecular Sequence Data, Multienzyme Complexes, Neoplastic Syndromes, Hereditary, Oxidoreductases, Paraganglioma, Pedigree, Succinate Dehydrogenase, Mutagenesis, Site-Directed, DNA, Complementary, Protein Subunits, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.